Dietary Recommendations for Reducing Free Sugar Intakes

June 9, 2025 updated by: Bournemouth University
This randomised controlled trial aims to assess the impacts of the current recommendations by Public Health England for reducing free sugar intakes, on total energy intakes of free sugar in a sample of the UK population.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The primary objective of this randomised control trial is to assess the impacts of Public Health England's (PHE) current free sugar reducing advice, for reducing total energy intakes (TEI) of free sugar. A total of 240 participants (age 18-65years) consuming diets >5% total energy intake from dietary free sugars will be recruited from across the Dorset region. Participants to be randomly assigned into the following recommendation interventions groups: 1) Reduce free sugar intake to <5% TEI (nutrient-based recommendations); 2) Reduce free sugar intake to <5% TEI, via reducing intake of specific foods identified as high in free sugars (nutrient- + food-based recommendations); 3) Reduce free sugar intake to <5% TEI, via reducing intake of specific foods identified as high in free sugars and replace/swap with low sugar versions (nutrient- + food-based recommendations with swaps); and 4) Control Group. The primary outcome will be changes in free sugar consumption from baseline to endpoint at week 12. Secondary outcomes include change in: BMI; dietary profiles; sweetness preference; sweetness liking; food choices; low calorie sweetener intakes and adherence levels.

Study Type

Interventional

Enrollment (Actual)

242

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • US And Canada Only
      • Bournemouth, US And Canada Only, United Kingdom, BH12 5BB
        • Bournemouth University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • aged 18-65 years;
  • able to provide consent and complete all study materials;
  • consuming >5% of TEI from free sugars; and
  • residing in the South of England.

Exclusion criteria:

  • individuals who are pregnant or breastfeeding;
  • underweight (BMI <18.5);
  • have pre-existing medical conditions affecting swallow ability, taste and smell perception;
  • currently or within 3 months of starting the study are following a specific dietary programme (e.g.: Slimming World);
  • current smokers or have smoked within 3 months of the study start date;
  • have pre-existing clinical conditions such as diabetes mellitus, eating disorders, Crohn's disease and other illness's leading to participants receiving external nutritional advice and dietary restrictions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nutrient-based recommendations
Participants in this group will be given nutrient-based recommendations to reduce free sugar intakes.
Dietary recommendations, with increasing additional behavioural/practical advice or no dietary recommendations
Experimental: Nutrient- and food-based recommendations
Participants in this group will be given nutrient- and food-based recommendations to reduce free sugar intakes.
Dietary recommendations, with increasing additional behavioural/practical advice or no dietary recommendations
Experimental: Nutrient- and food-based recommendations with food swaps
Participants in this group will be given nutrient- and food-based recommendations and advice on food swaps to reduce free sugar intakes.
Dietary recommendations, with increasing additional behavioural/practical advice or no dietary recommendations
Placebo Comparator: Control
Participants in this group will not be given any recommendations to reduce free sugar intakes.
Dietary recommendations, with increasing additional behavioural/practical advice or no dietary recommendations

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Free Sugar Intakes
Time Frame: 12 weeks from baseline
Percentage energy intake from free sugars, assessed using diet diaries
12 weeks from baseline
Number of Participants Who Adhered to the Recommendations Provided
Time Frame: 12 weeks from baseline
Adherence to the recommendations provided, assessed using diet diaries and self-reported adherence
12 weeks from baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BMI
Time Frame: 12 weeks from baseline
Body Mass Index, assessed using researcher measurements or researcher-observed self-measurements
12 weeks from baseline
Dietary Intakes
Time Frame: 12 weeks from baseline
Energy intake, assessed using diet diaries
12 weeks from baseline
Sweet Food Preferences
Time Frame: 12 weeks from baseline
Preferences for various sweet foods/fluids, assessed using a taste test, where participants sample several sweet and non-sweet foods and rate them for pleasantness on a 100mm Visual Analogue Scale. Higher scores signify stronger preferences
12 weeks from baseline
Sweet Food Choices
Time Frame: 12 weeks from baseline
Selection of sweet foods/fluids at a given meal, assessed where participants can consume freely from a meal composed of sweet and non-sweet foods, and proportion of sweet foods consumed is measured in terms of weight consumed
12 weeks from baseline
Sweet Food Attitudes
Time Frame: 12 weeks from baseline
Attitudes towards sugar, sweeteners, and sweet-tasting foods, assessed using a questionnaire, soon to be published. Higher scores denote stronger attitudes.
12 weeks from baseline
Number of Participants Reporting Adverse Events
Time Frame: Baseline to 12 weeks
Adverse events, assessed by self-report
Baseline to 12 weeks
Eating-based Attitudes
Time Frame: Baseline to 12 weeks
Attitudes towards eating, assessed using the Three Factor Eating Questionnaire (Karlsson J, et al. IJO 2000; 24: 1715-1725)
Baseline to 12 weeks
Eating-based Motivations
Time Frame: Baseline to 12 weeks
Motivations towards eating, assessed using the Food Choice Questionnaire (Steptoe et al., Appetite 1995, 25(3): 267-84). Higher scores denote stronger motivations
Baseline to 12 weeks
Quality of Life (Subjective Wellbeing)
Time Frame: Baseline to 12 weeks
Quality of Life, measured using the SF-36 questionnaire (Ware et al, 1996), where Quality of Life is assessed out of 100, where a higher score demonstrates better quality of life
Baseline to 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Katherine Appleton, Bournemouth University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2021

Primary Completion (Actual)

December 20, 2022

Study Completion (Actual)

January 31, 2024

Study Registration Dates

First Submitted

March 17, 2021

First Submitted That Met QC Criteria

March 24, 2021

First Posted (Actual)

March 25, 2021

Study Record Updates

Last Update Posted (Actual)

June 10, 2025

Last Update Submitted That Met QC Criteria

June 9, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • PhDBoxall

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymised study data will be available on completion of the trial from the PI

IPD Sharing Time Frame

On study completion

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dietary Recommendations

Clinical Trials on Dietary recommendations

Subscribe